After the action of nitidine chloride on human BRCA cells, it was found that the drug could significantly reduce the expression levels of p-ERK1/2, p-JNK, and p-p38, indicating that nitidine chloride could inhibit the activity of the MAPK signaling pathway and inhibit the metastasis of breast tumors. This evidence concerns the gene MAPK8 and breast neoplasm.